Johnson & Johnson’s PROTEUS Phase 3 trial shows apalutamide + hormone therapy before/after surgery improves outcomes in ...
The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results